Enhabit lowered its 2024 earnings and revenue guidance, causing its stock to dip to $7.89.

Enhabit, a U.S. home health and hospice services provider, lowered its FY 2024 earnings and revenue guidance below analyst expectations. Despite this, the company beat earnings estimates in the last quarter. Its stock price slightly declined to $7.89 on the news. Enhabit offers services like patient education and wound care.

November 10, 2024
4 Articles

Further Reading